SEC Form 4 · accession 0000899243-17-007152
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas J Virca
Officer — President and CEO
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 8, 2017 | M | 15,041,738 | — | A | 15,041,738 | D | |
| Common Stock | Mar 8, 2017 | F | 6,314,219 | $0.34 | D | 8,727,519 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 8, 2017 | M | 15,041,738 | D | — | — | Common Stock | 15,041,738 | 0 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- F2The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.